Ignite Creation Date:
2024-05-06 @ 7:10 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05919108
Status:
RECRUITING
Last Update Posted:
2024-06-13
First Post:
2023-06-15
Brief Title:
Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers
Sponsor:
Organization:
Vanderbilt-Ingram Cancer Center